Rallybio Corp (RLYB) stock
RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)
Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –
Rallybio gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Rallybio
Rallybio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?